Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alba, Shire in AT-1001 deal

Alba (Baltimore, Md.) granted Shire (LSE:SHP; SHPGY) exclusive rights to commercialize AT-1001 outside the

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE